MINNEAPOLIS, Feb. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation (TECH) and Cell Signaling Technology (CST) announced today the addition of Simple Western™ validation to CST antibodies. This will ...
MINNEAPOLIS, April 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system that ...
Analyzing protein expression in biological samples has traditionally been challenging and often poorly reproducible. While methods like western blot have been around for decades, Simple Western™ ...
MINNEAPOLIS, March 10, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has begun shipping the Leo™ System, powered by Simple Western™ Technology. Leo expands upon ...
MINNEAPOLIS, July 14, 2025 /PRNewswire/ -- Bio-Techne Corporation (TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene ...
The Western blot remains widely used, despite facing many challenges—such as poor quantitation, high variability, and large time, sample consumption, and labor requirements. Simple Western™ platforms, ...
Simple Western reinvents how Westerns are done. Automating all steps from protein separation, immunoprobing, detection, and analysis of data, it finally offers researchers an analytical tool that ...
ProteinSimple today introduced a revolutionary new system for protein analysis, Simon and the Simple Western. The Simple Western is a complete reinvention of the Western Blot, and is truly a historic ...
Discover a new and simple way to advance your protein research with automated solutions from Bio-Techne! Our virtual event series will showcase how you can leverage these revolutionary technologies to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results